Caregen
Daily close in US$ at the latest USD/KRW close. Source: KRX via FinanceDataReader.
Caregen develops and supplies peptide-based ingredients and formulations used in cosmetics and hair-care products, as well as pharmaceutical and medical-aesthetic applications.
Its customers include cosmetic brands, clinics, and other companies that incorporate its active ingredients into their own finished products. Listed on KOSDAQ, South Korea's technology and small-cap exchange, the company conducts its own research and development as a core part of its business model.
Summary is AI-generated and may contain errors · figures from DART filings
Caregen in five facts
What does Caregen do?
Caregen develops and supplies peptide-based ingredients and formulations used in cosmetics and hair-care products, as well as pharmaceutical and medical-aesthetic applications.
Where is Caregen listed and in which sector?
Caregen (Korean name: 케어젠) trades under KRX code 214370 on KOSDAQ, the Korea Exchange's board for smaller and growth companies. It is classified in the Health Care sector, Pharmaceuticals.
How large is Caregen?
Its market capitalisation was US$1.6B on 2026-10-21, which puts it in this site's large-cap group. US$ amounts are converted from won at 1 USD ≈ ₩1,325 (2026-10-21).
What were Caregen's latest annual revenue and operating profit?
For fiscal year 2025, Caregen reported revenue of US$55M, operating profit of US$15.4M and net income of US$15.2M, per its annual report on DART (data retrieved from DART on 2026-09-17). Revenue was down 11.8% on the previous year.
Where does this data come from?
Financial statements and filings come from DART, Korea's official corporate-filing system. Share prices, market capitalisation and trading status come from KRX. Company summaries are AI-generated from the filings and may contain errors; financial figures are mapped directly from DART.
Data sources and last updated
- Filings and financial statements
- DART (dart.fss.or.kr), Korea's official corporate-filing system
- Prices, market cap, trading status
- KRX (Korea Exchange), via FinanceDataReader
- Latest annual financials
- Fiscal year 2025, data retrieved from DART on 2026-09-17
- Share price and market cap
- Close of 2026-10-21
- Currency
- US$, converted from won at 1 USD ≈ ₩1,325 (2026-10-21 close)
- Company data updated
- 2026-10-21
- Company summary
- AI-generated from filings; may contain errors. Information only, not investment advice.
- Report on securities held by executives/major shareholdersOct 1
- Report on large shareholdings (5% rule) (standard)Sep 29
- Report on large shareholdings (5% rule) (standard)Sep 28
- Report on large shareholdings (5% rule) (standard)Sep 23
- Cash/in-kind dividend decision (interim dividend)
Caregen declared a cash dividend of US$0.13 per share, equal to about 0.3% of the recent share price.
Dividend · Jul 3 - Supply contract terminated (voluntary)Supply contract · May 29
- Supply contract terminatedSupply contract · May 29
- Operating results (consolidated) (preliminary) (fair disclosure)
Caregen filed provisional (unaudited) consolidated results for Q1 2026: revenue of US$15.4M (+6.63% year on year), operating profit of US$6.93M (+0.45% year on year) and net income of US$7.93M (+38.72% year on year).
Earnings · Apr 30 - Change of 30% or more in revenue or profit/loss structure (15% for large companies)
Caregen reported consolidated results for FY2025: revenue of US$49.5M (−11.8% year on year), operating profit of US$13.9M (−40.4% year on year) and net income of US$13.7M (−37.8% year on year).
Earnings · Mar 13 - Cash/in-kind dividend decision
Caregen declared a cash dividend of US$0.13 per share, equal to about 0.31% of the recent share price.
Dividend · Mar 9